TOP STORIES

• BUSINESS Shionogi Chief Confident about 70% Market Share for Xofluza in Japan
  October 30, 2018

• ORGANIZATION Limit CEA Application to Premium-Given Drugs with Big Sales: EFPIA Japan Officials
  October 29, 2018

• ORGANIZATION EFPIA Japan Chief Eyes New Funding Model for Innovative but Pricey Therapies
  October 26, 2018

• BUSINESS Tecentriq, Hemlibra Get Off with a Bang, Clear 2018 Targets Already: Chugai
  October 25, 2018

• BUSINESS AVXS-101 Is Game Changer for SMA Treatment: Novartis Neuroscience Chief
  October 24, 2018

• BUSINESS Parexel CEO Sees Bright Future for Japan CRO Market
  October 23, 2018

• BUSINESS Mundipharma Shooting for Japan Sales of US$500 Million in 10 Years: CEO
  October 22, 2018

• BUSINESS Prescribers Asked to Stop New Enbrel Biosimilar Use as Maker Can’t Keep Up with Demand
  October 19, 2018

• REGULATORY 3 Pharma Groups Warn against Drug Price Cut in April 2019: Chuikyo
  October 18, 2018

• BUSINESS JAK Inhibitor Battle for Atopic Dermatitis Intensifying, 1st Japan Filing Might Be Near
  October 17, 2018

• REGULATORY As Abe Vows to Deliver on Tax Hike Plan, 3 Pharma Groups to Push for October 2019 Price Revision
  October 16, 2018

• REGULATORY MEXT Kicks Off “Open Innovation Organization” Initiative, 3 Universities to Push Drug Discovery
  October 15, 2018

• BUSINESS Chugai Sues Daiichi Sankyo, Pfizer over Herceptin Biosimilars
  October 15, 2018

• TRENDS Hep C Market Shrinking towards Disease Elimination in 2030
  October 12, 2018

• BUSINESS Nippon Shinyaku to Expand Contract Manufacturing Biz with New Facility to Start Full Operation in Feb.
  October 12, 2018

• REGULATORY MHLW Panelists Frown on Use of Economic Evaluations for Reimbursement Decisions
  October 11, 2018

• REGULATORY MOF Reiterates Drug Cost Optimization, but Makes No Fresh Proposal: Fiscal System Council
  October 10, 2018

• BUSINESS Funding Disclosures Reveal Changes in Money Flows; Biz Models, Pricing Reform Driving the Shift
  October 9, 2018

• BUSINESS Amgen to Remain Active Investor in Japan as It Eyes 2020 Launch of Stand-Alone Subsidiary
  October 4, 2018

• BUSINESS Bavencio on Back Foot, but Merck KGaA Has High Hopes for Next-Gen I/O Therapy M7824
  October 3, 2018

ページ

• « 先頭
• ‹ Prev
• …
• 130
• 131
• 132
• 133
• 134
• 135
• 136
• 137
• 138
• …
• Next ›
• 最終 »